POLYNEURON

About:

Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.

Website: http://polyneuron.com

Twitter/X: polyneuron

Top Investors: Venture Kick, New Enterprise Associates, Zürcher Kantonal Bank, Gebert Rüf Stiftung, Sofinnova Partners

Description:

Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders in a safe and effective manner.